Point of care diagnosis of dry eye disease with a sensitive immunoassay for dual biomarker detection
Dry eye disease (DED) is a multifactorial eye disease with few effective methods for clinical diagnosis and treatment. It is the most common eye disease with significant health challenges of the unprecedented aging population. Recent proteomic studies and clinical research have led to the discovery...
Main Authors: | Sydney Zhang, Julio Echegoyen |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-12-01
|
Series: | Biochemistry and Biophysics Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2405580822001960 |
Similar Items
-
Design and Usability Study of a Point of Care mHealth App for Early Dry Eye Screening and Detection
by: Sydney Zhang, et al.
Published: (2023-10-01) -
Patient stratification using point of care biomarkers in dry eye disease
by: Rohit Shetty, et al.
Published: (2023-01-01) -
Air Pollution and Tear Lactoferrin among Dry Eye Disease Modifications by Stress and Allergy: A Case–Control Study of Taxi Drivers
by: Wei Hao, et al.
Published: (2022-11-01) -
Therapeutic Effects of Lactoferrin in Ocular Diseases: From Dry Eye Disease to Infections
by: Aldo Vagge, et al.
Published: (2020-09-01) -
Development of Lactoferrin-Loaded Liposomes for the Management of Dry Eye Disease and Ocular Inflammation
by: Ana López-Machado, et al.
Published: (2021-10-01)